Zacks Research Brokers Boost Earnings Estimates for Integer

Integer Holdings Co. (NYSE:ITGR) – Equities researchers at Zacks Research raised their FY2024 earnings estimates for Integer in a research note issued on Tuesday, January 7th. Zacks Research analyst D. Dey now expects that the medical equipment provider will post earnings per share of $5.33 for the year, up from their prior forecast of $5.32. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q1 2025 earnings at $1.32 EPS, Q4 2025 earnings at $1.67 EPS, Q2 2026 earnings at $1.55 EPS and Q4 2026 earnings at $1.76 EPS.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the business posted $1.27 EPS.

A number of other analysts also recently issued reports on ITGR. Benchmark lifted their price objective on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. Piper Sandler restated an “overweight” rating and set a $140.00 price objective (up from $125.00) on shares of Integer in a research note on Friday, October 25th. Bank of America raised their price objective on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Citigroup increased their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Finally, KeyCorp upped their price objective on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $145.44.

Integer Stock Up 0.7 %

Shares of Integer stock opened at $133.13 on Thursday. Integer has a 52-week low of $94.56 and a 52-week high of $142.76. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The business’s 50 day simple moving average is $135.73 and its 200 day simple moving average is $127.72. The firm has a market cap of $4.47 billion, a PE ratio of 41.09, a P/E/G ratio of 1.99 and a beta of 1.12.

Hedge Funds Weigh In On Integer

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Contravisory Investment Management Inc. grew its position in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares during the last quarter. HighTower Advisors LLC grew its holdings in Integer by 0.8% in the 3rd quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock valued at $1,579,000 after buying an additional 90 shares in the last quarter. Xponance Inc. grew its holdings in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after buying an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV increased its position in Integer by 0.9% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock worth $1,504,000 after buying an additional 107 shares during the period. Finally, Versant Capital Management Inc boosted its position in shares of Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares during the period. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.